B

iotech stocks are risky, volatile, and potentially worth a fortune. But are they biblically sound?

Some evangelical investors are betting Christian-friendly stocks can outperform the market, and they’re leaning heavily on biotech to prove them right.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • ‘“That’s what we call inspiring transformation,” Netzly said.’

    Since scientists are overwhelmingly non-religious, imposing religion on biotechs will inspire an exodus or two and “Inspire” will be radioactive.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.